Washington Medicaid coverage for Wegovy (Weight Loss)

Semaglutide injection or tablet (Wegovy) is not covered by Apple Health for weight loss in accordance with WAC 182-530-2100(1)(b)(i) and SEC. 1927 [42 U.S.C. 1396r-8](d)(2)(A).

Policy note: Weight loss is explicitly non-covered under Apple Health (Washington Medicaid) per state regulation WAC 182-530-2100(1)(b)(i) and federal statute 42 U.S.C. 1396r-8(d)(2)(A), which excludes agents used for weight gain or loss from Medicaid coverage. Both injection and tablet formulations are excluded for this indication.

Policy effective February 1, 2026 · verified June 4, 2026 · source: semaglutide.pdf